369 related articles for article (PubMed ID: 28484033)
21. Supercharging BRD4 with NUT in carcinoma.
Eagen KP; French CA
Oncogene; 2021 Feb; 40(8):1396-1408. PubMed ID: 33452461
[TBL] [Abstract][Full Text] [Related]
22. The importance of diagnosing NUT midline carcinoma.
French CA
Head Neck Pathol; 2013 Mar; 7(1):11-6. PubMed ID: 23463074
[TBL] [Abstract][Full Text] [Related]
23. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.
Grayson AR; Walsh EM; Cameron MJ; Godec J; Ashworth T; Ambrose JM; Aserlind AB; Wang H; Evan G; Kluk MJ; Bradner JE; Aster JC; French CA
Oncogene; 2014 Mar; 33(13):1736-1742. PubMed ID: 23604113
[TBL] [Abstract][Full Text] [Related]
24. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of NUT midline carcinoma by epigenomic reprogramming.
Schwartz BE; Hofer MD; Lemieux ME; Bauer DE; Cameron MJ; West NH; Agoston ES; Reynoird N; Khochbin S; Ince TA; Christie A; Janeway KA; Vargas SO; Perez-Atayde AR; Aster JC; Sallan SE; Kung AL; Bradner JE; French CA
Cancer Res; 2011 Apr; 71(7):2686-96. PubMed ID: 21447744
[TBL] [Abstract][Full Text] [Related]
26. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
[TBL] [Abstract][Full Text] [Related]
27. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
[TBL] [Abstract][Full Text] [Related]
28. Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature.
Raza A; Cao H; Conrad R; Cobb C; Castelino-Prabhu S; Mirshahidi S; Shiraz P; Mirshahidi HR
Expert Rev Anticancer Ther; 2015; 15(10):1199-213. PubMed ID: 26402248
[TBL] [Abstract][Full Text] [Related]
29. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
[TBL] [Abstract][Full Text] [Related]
30. Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma.
Yu D; Liang Y; Kim C; Jaganathan A; Ji D; Han X; Yang X; Jia Y; Gu R; Wang C; Zhang Q; Cheung KL; Zhou MM; Zeng L
Nat Commun; 2023 Jan; 14(1):378. PubMed ID: 36690674
[TBL] [Abstract][Full Text] [Related]
31. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
32. The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
Durall RT; Huang J; Wojenski L; Huang Y; Gokhale PC; Leeper BA; Nash JO; Ballester PL; Davidson S; Shlien A; Sotirakis E; Bertaux F; Dubus V; Luo J; Wu CJ; Keskin DB; Eagen KP; Shapiro GI; French CA
Cancer Res; 2023 Dec; 83(23):3846-3860. PubMed ID: 37819236
[TBL] [Abstract][Full Text] [Related]
33. Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.
Sakamaki JI; Wilkinson S; Hahn M; Tasdemir N; O'Prey J; Clark W; Hedley A; Nixon C; Long JS; New M; Van Acker T; Tooze SA; Lowe SW; Dikic I; Ryan KM
Mol Cell; 2017 May; 66(4):517-532.e9. PubMed ID: 28525743
[TBL] [Abstract][Full Text] [Related]
34. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
35. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
French CA
Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
[TBL] [Abstract][Full Text] [Related]
36. NUT midline carcinoma.
French CA
Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
[TBL] [Abstract][Full Text] [Related]
37. NUT midline carcinoma of the larynx: an international series and review of the literature.
Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
[TBL] [Abstract][Full Text] [Related]
38. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
Bishop JA; French CA; Ali SZ
Cancer Cytopathol; 2016 Dec; 124(12):901-908. PubMed ID: 27400194
[TBL] [Abstract][Full Text] [Related]
39. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.
Wang R; Cao XJ; Kulej K; Liu W; Ma T; MacDonald M; Chiang CM; Garcia BA; You J
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5352-E5361. PubMed ID: 28630312
[TBL] [Abstract][Full Text] [Related]
40. Demystified molecular pathology of NUT midline carcinomas.
French CA
J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]